First human test for new Weight-Loss injection begins
NCT ID NCT07479862
Summary
This is the first study to give the experimental drug SA030 to people. Researchers want to see if a single injection is safe and how the body handles it in 40 healthy adults who are overweight or obese. The main goal is to check for side effects and understand how the drug moves through the body, while also looking for early signs of any effect on weight or body measurements.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CMAX Clinical Research Pty Ltd North Terrace
Adelaide, 5000, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.